📣 New systematic review:
#Methenamine has been shown in RCTs to be effective #antibiotic-sparing prophylaxis for recurrent #UTI 💊
Fassbind et al ask whether it can be effective as #prophylaxis before endo-urological #surgery, too
#IDSky #UTISky #AMR #Pharmsky
www.cmi-comms.org/article/S295...
#Methenamine has been shown in RCTs to be effective #antibiotic-sparing prophylaxis for recurrent #UTI 💊
Fassbind et al ask whether it can be effective as #prophylaxis before endo-urological #surgery, too
#IDSky #UTISky #AMR #Pharmsky
www.cmi-comms.org/article/S295...
Methenamine hippurate for prevention of urinary tract infections after endourological procedures: a systematic review
Urinary tract infections (UTIs) are among the most common infections worldwide and
a major driver of antimicrobial use and, consequently, antimicrobial resistance [1].
In urology, antibiotics are freq...
www.cmi-comms.org
November 9, 2026 at 3:32 AM
Are Higher-Order Carbapenems Effective Therapy for Patients with Ertapenem-Resistant Enterobacterales Invasive Infections?
✅ Just Accepted
🔗 https://bit.ly/4BOQ3LO
✅ Just Accepted
🔗 https://bit.ly/4BOQ3LO
November 9, 2026 at 2:04 PM
Empirical Antifungal Treatment of Critically Ill Patients With Influenza-Associated Acute Respiratory Distress Syndrome: A Bayesian Perspective
🔁 Repost
https://t.co/xIS84kOkFS
🔁 Repost
https://t.co/xIS84kOkFS
Empirical Antifungal Treatment of Critically Ill Patients With Influenza-Associated Acute Respiratory Distress Syndrome: A Bayesian Perspective
t.co
November 9, 2026 at 12:12 PM
Empirical Antifungal Treatment of Critically Ill Patients With Influenza-Associated Acute Respiratory Distress Syndrome: A Bayesian Perspective
🔁 Repost
https://t.co/xIS84kOkFS
🔁 Repost
https://t.co/xIS84kOkFS
Empirical Antifungal Treatment of Critically Ill Patients With Influenza-Associated Acute Respiratory Distress Syndrome: A Bayesian Perspective
t.co
November 9, 2026 at 2:03 PM
Recurrent Tuberculosis Among People Living with HIV in a High-Burden Setting of Andhra Pradesh, India, 2017–2023: Findings from a Cohort Study
✅ Just Accepted
🔗 https://bit.ly/4sJbr0S
✅ Just Accepted
🔗 https://bit.ly/4sJbr0S
November 9, 2026 at 3:31 AM
Empirical Antifungal Treatment of Critically Ill Patients With Influenza-Associated Acute Respiratory Distress Syndrome: A Bayesian Perspective
🔁 Repost
https://t.co/xIS84kOkFS
🔁 Repost
https://t.co/xIS84kOkFS
Empirical Antifungal Treatment of Critically Ill Patients With Influenza-Associated Acute Respiratory Distress Syndrome: A Bayesian Perspective
t.co
November 9, 2026 at 2:56 AM
A New Outlook on Infection-Associated Chronic Conditions and Illnesses
✅ Just Accepted
🔗 https://bit.ly/4z2JCCw
✅ Just Accepted
🔗 https://bit.ly/4z2JCCw
November 9, 2026 at 2:52 AM
Are Higher-Order Carbapenems Effective Therapy for Patients with Ertapenem-Resistant Enterobacterales Invasive Infections?
✅ Just Accepted
🔗 https://bit.ly/4BOQ3LO
✅ Just Accepted
🔗 https://bit.ly/4BOQ3LO
November 9, 2026 at 2:46 AM
Pilot Randomized Trial of Patient-Directed vs Fixed-Antibiotic Duration in Acute Pyelonephritis
✅ Just Accepted
⭐ Editor's Choice
🔗 https://bit.ly/4BOluGe
✅ Just Accepted
⭐ Editor's Choice
🔗 https://bit.ly/4BOluGe
November 9, 2026 at 2:45 AM
Pilot Randomized Trial of Patient-Directed vs Fixed-Antibiotic Duration in Acute Pyelonephritis
✅ Just Accepted
⭐ Editor's Choice
🔗 https://bit.ly/4BOluGe
✅ Just Accepted
⭐ Editor's Choice
🔗 https://bit.ly/4BOluGe
November 8, 2026 at 10:39 PM
Protection Induced by a Novel Circumsporozoite Protein Malaria Vaccine is Associated with the Quality of Antibody Responses
✅ Just Accepted
🔗 https://bit.ly/4iLqcvO
✅ Just Accepted
🔗 https://bit.ly/4iLqcvO
November 8, 2026 at 10:39 PM
From our issue: New data from the PETERPEN trial suggest that piperacillin-tazobactam may be noninferior to meropenem for early clinical outcomes in select patients with ESBL bloodstream infections, but carbapenems remain the standard of care until final mortality results are available. #IDsky
Carbapenem-Sparing Therapy for ESBL Bacteremia: New Trials, Old Questions | Contagion Live
New data from the PETERPEN trial suggest that piperacillin-tazobactam may be noninferior to meropenem for early clinical outcomes in select patients with ESBL bloodstream infections, but carbapenems r...
www.contagionlive.com
November 9, 2026 at 1:28 AM
Are Higher-Order Carbapenems Effective Therapy for Patients with Ertapenem-Resistant Enterobacterales Invasive Infections?
✅ Just Accepted
🔗 https://bit.ly/4BOQ3LO
✅ Just Accepted
🔗 https://bit.ly/4BOQ3LO
November 8, 2026 at 8:49 PM
IDSA and ESCMID released 7 consensus statements to assist in managing individuals with SAB. This review will focus on the adult patient population and additional information on pediatric population statements can be assessed in the guideline. #IDsky
IDSA/ESCMID Statement on Staphylococcus aureus: Follow-Up Blood Cultures | Contagion Live
IDSA and ESCMID released 7 consensus statements to assist in managing individuals with SAB. This review will focus on the adult patient population and additional information on pediatric population st...
www.contagionlive.com
November 9, 2026 at 12:11 PM
Staphylococcus aureus (often called staph or S. aureus) is a major bacterial germ that causes approximately one million deaths each year.
In @lancetmicrobe.bsky.social, authors summarise methods of detection, treatment, & prevention, as well as knowledge gaps for further study: spkl.io/633257wngR
In @lancetmicrobe.bsky.social, authors summarise methods of detection, treatment, & prevention, as well as knowledge gaps for further study: spkl.io/633257wngR
November 8, 2026 at 6:30 PM
DYK? About 1 in 9 patients who get a C. diff infection will get it again within 2-8 weeks.
This #CdiffAwarenessMonth, learn how to lower your risk: https://bit.ly/4zsn0Mz
This #CdiffAwarenessMonth, learn how to lower your risk: https://bit.ly/4zsn0Mz
November 8, 2026 at 6:12 PM
Searching for the Optimal Treatment of Infections due to Non-Carbapenemase-Producing Carbapenem-resistant Enterobacterales
✅ Just Accepted
🔗 https://bit.ly/4z9fHse
✅ Just Accepted
🔗 https://bit.ly/4z9fHse
November 8, 2026 at 6:11 PM
Shotgun metagenomics versus 16S rDNA Sanger sequencing for the diagnosis of blood culture-negative endocarditis: a draw?
✅ Just Accepted
🔗 https://bit.ly/4BO9CUA
✅ Just Accepted
🔗 https://bit.ly/4BO9CUA
November 8, 2026 at 6:11 PM
The in vitro activity of daptomycin and ampicillin combination in Enterococcus faecalis depends on the daptomycin susceptibility phenotype
✅ Just Accepted
🔗 https://bit.ly/4iCdEIp
✅ Just Accepted
🔗 https://bit.ly/4iCdEIp
November 8, 2026 at 8:50 PM
Myths and Misconceptions About Modern Antiretroviral Therapy for HIV Treatment
✅ Just Accepted
🔗 https://bit.ly/4k2TLvc
✅ Just Accepted
🔗 https://bit.ly/4k2TLvc
November 9, 2026 at 2:52 AM
DYK? About 1 in 9 patients who get a C. diff infection will get it again within 2-8 weeks.
This #CdiffAwarenessMonth, learn how to lower your risk: https://bit.ly/4zsn0Mz
This #CdiffAwarenessMonth, learn how to lower your risk: https://bit.ly/4zsn0Mz
November 8, 2026 at 6:32 PM
IDSA and ESCMID released 7 consensus statements to assist in managing individuals with SAB. This review will focus on the adult patient population and additional information on pediatric population statements can be assessed in the guideline. #IDsky
IDSA/ESCMID Statement on Staphylococcus aureus: Follow-Up Blood Cultures | Contagion Live
IDSA and ESCMID released 7 consensus statements to assist in managing individuals with SAB. This review will focus on the adult patient population and additional information on pediatric population st...
www.contagionlive.com
November 9, 2026 at 1:28 AM
Myths and Misconceptions About Modern Antiretroviral Therapy for HIV Treatment
✅ Just Accepted
🔗 https://bit.ly/4k2TLvc
✅ Just Accepted
🔗 https://bit.ly/4k2TLvc
November 8, 2026 at 6:12 PM
On IDSA’s & HIVMA’s Science Speaks blog: What happens when the recommended antibiotic is not on the shelf? Sameer Alzaidi, PharmD, MBAc, BCPS, BCIDP, AAHIVP, explores how to rethink antimicrobial stewardship during drug shortages. https://bit.ly/4Ac6rof
When the recommended antibiotic isn't available: Rethinking antimicrobial stewardship during drug shortages
Stewardship is built around a simple principle: Give the right antibiotic, to the right patient, at the right dose, for the right duration. What happens when the “right” antibiotic is not on the shelf?
bit.ly
November 8, 2026 at 6:12 PM
Recurrent Tuberculosis Among People Living with HIV in a High-Burden Setting of Andhra Pradesh, India, 2017–2023: Findings from a Cohort Study
✅ Just Accepted
🔗 https://bit.ly/4sJbr0S
✅ Just Accepted
🔗 https://bit.ly/4sJbr0S
November 8, 2026 at 6:11 PM